Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.22
+0.09 (1.75%)
At close: May 12, 2025, 4:00 PM
5.35
+0.13 (2.49%)
After-hours: May 12, 2025, 6:14 PM EDT
Precision BioSciences Stock Forecast
DTIL's stock price has decreased by -50.94% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Precision BioSciences stock have an average target of 47, with a low estimate of 34 and a high estimate of 60. The average target predicts an increase of 800.38% from the current stock price of 5.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 28, 2025.
Analyst Ratings
The average analyst rating for Precision BioSciences stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Buy | 0 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,049.43% | Mar 28, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,049.43% | Mar 19, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,049.43% | Feb 19, 2025 |
BMO Capital | BMO Capital | Hold → Buy Upgrades $34 | Hold → Buy | Upgrades | $34 | +551.34% | Jan 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,049.43% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
22.41M
from 68.70M
Decreased by -67.38%
Revenue Next Year
29.17M
from 22.41M
Increased by 30.20%
EPS This Year
-6.51
from 1.04
EPS Next Year
-3.41
from -6.51
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 47.9M | 69.8M | 79.5M | ||
Avg | 22.4M | 29.2M | 32.0M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -30.3% | 211.6% | 172.5% | ||
Avg | -67.4% | 30.2% | 9.6% | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | -1.23 | 0.06 | 0.22 | |
Avg | -6.51 | -3.41 | -2.84 | |
Low | -9.67 | -6.08 | -5.15 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.